Display options
Share it on

Obstet Gynecol Sci. 2015 Sep;58(5):385-90. doi: 10.5468/ogs.2015.58.5.385. Epub 2015 Sep 22.

Prediction of lymph node metastasis in patients with apparent early endometrial cancer.

Obstetrics & gynecology science

Joo-Hyuk Son, Tae-Wook Kong, Su Hyun Kim, Jiheum Paek, Suk-Joon Chang, Eun Ju Lee, Hee-Sug Ryu

Affiliations

  1. Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
  2. Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
  3. Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. ; Department of Radiology, Ajou University School of Medicine, Suwon, Korea.

PMID: 26430663 PMCID: PMC4588843 DOI: 10.5468/ogs.2015.58.5.385

Abstract

OBJECTIVE: The purpose of this study is to investigate the incidence of lymph node metastasis in early endometrial cancer patients and to evaluate preoperative clinicopathological factors predicting lymph node metastasis.

METHODS: We identified 142 patients with endometrial cancer between January 2000 and February 2013. All patients demonstrated endometrioid adenocarcinoma with grade 1 or 2 on preoperative endometrial biopsy. Preoperative magnetic resonance imaging showed that tumors were confined to the uterine corpus with superficial myometrial invasion (less than 50%), and there were no lymph nodes enlargements. All patients had complete staging procedures and were surgically staged according to the 2009 FIGO (International Federation of Gynecology and Obstetrics) staging system. Clinical and pathological data were obtained from medical records and statistically analyzed.

RESULTS: Of the 142 patients, 127 patients (89.4%) presented with stage 1A, 8 (5.6%) with stage IB, 3 (2.1%) with stage II, and 4 (2.8%) with stage III disease. Three patients (2.1%) had lymph node metastasis-2 IIIC1 and 1 IIIC2 disease. Age, preoperative tumor grade, and myometrial invasion less than 50% on preoperative MRI were not associated with lymph node metastasis. A high preoperative serum CA-125 level (>35 IU/mL) was a statistically significant factor for predicting lymph node metastasis on univariate and multivariate analyses. Lymph node metastasis was only found in patients with preoperative grade 2 tumors or a high serum CA-125 level.

CONCLUSION: Preoperative tumor grade and serum CA-125 level can predict lymph node metastasis in apparent early endometrial cancer patients.

Keywords: CA-125; Endometrial neoplasms; Lymph node; Metastasis; Tumor grade

References

  1. Lancet. 2009 Jan 10;373(9658):125-36 - PubMed
  2. J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16 - PubMed
  3. Int J Gynecol Cancer. 2012 Oct;22(8):1373-7 - PubMed
  4. Acta Obstet Gynecol Scand. 2010;89(2):168-74 - PubMed
  5. J Reprod Med. 2005 Aug;50(8):585-90 - PubMed
  6. Cancer. 1992 Aug 15;70(4):790-8 - PubMed
  7. J Clin Oncol. 2005 Jun 1;23(16):3668-75 - PubMed
  8. Gynecol Oncol. 2013 Jun;129(3):500-4 - PubMed
  9. Gynecol Oncol. 2010 Apr;117(1):6-8 - PubMed
  10. Acta Obstet Gynecol Scand. 2006;85(12):1501-5 - PubMed
  11. Curr Opin Obstet Gynecol. 2009 Feb;21(1):10-4 - PubMed
  12. Obstet Gynecol Int. 2012;2012:578490 - PubMed
  13. CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
  14. Gynecol Oncol. 1998 Aug;70(2):165-71 - PubMed
  15. Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:115-9 - PubMed
  16. J Clin Oncol. 2012 Apr 20;30(12):1329-34 - PubMed
  17. Int J Cancer. 2012 Aug 15;131(4):885-90 - PubMed
  18. Int J Clin Oncol. 2013 Apr;18(2):193-9 - PubMed
  19. Obstet Gynecol. 2005 Aug;106(2):413-25 - PubMed
  20. Eur J Surg Oncol. 2013 Apr;39(4):350-7 - PubMed

Publication Types